Abiopharma

New Form DEF 14A - DBV Technologies S.A. Filed: 2025-05-15 AccNo: 0001193125-25-120788 Size: 5 MB

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Sensus Healthcare Reports First Quarter 2025 Financial Results

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

New Form S-3 - Modular Medical, Inc. Filed: 2025-05-15 AccNo: 0001213900-25-044188 Size: 749 KB

New Form 4 - EyePoint Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001562180-25-003873 Size: 7 KB

New Form 4 - Allakos Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049419 Size: 7 KB

New Form S-3 - Lifeward Ltd. Filed: 2025-05-15 AccNo: 0001178913-25-001819 Size: 1 MB

New Form NT 10-Q - ReShape Lifesciences Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049418 Size: 24 KB

New Form 144 - EXELIXIS, INC. Filed: 2025-05-15 AccNo: 0001950047-25-003045 Size: 7 KB

New Form SCHEDULE 13G/A - BIOTRICITY INC. Filed: 2025-05-15 AccNo: 0001753926-25-000848 Size: 19 KB

New Form S-8 - Anebulo Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001641172-25-010854 Size: 149 KB

New Form NT 10-Q - UpHealth, Inc. Filed: 2025-05-15 AccNo: 0001193125-25-120779 Size: 23 KB

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

New Form SCHEDULE 13G/A - ALX ONCOLOGY HOLDINGS INC Filed: 2025-05-15 AccNo: 0001104659-25-049410 Size: 7 KB